Osmetech presentó test para la influenza porcina a la FDA

Osmetech anunció que ha presentado una solicitud a la US FDA para la Autorización de Uso para Emergencias (EUA) de su Panel de Prueba de Patógenos Respiratorios para ser empleado en la investigación del virus de la gripe porcina
http://www.medicalnewstoday.com/articles/150455.php

Osmetech’s Respiratory Pathogen Test Panel test, which is expected to be launched as a research use only (RUO) product next quarter, detects and differentiates between 18 common bacterial and viral infections, including the Influenza A virus and its H1N1 subtype. Osmetech is currently developing an extension to the Respiratory Pathogen Test that will differentiate this H1N1 subtype between the human and swine forms of the virus.

Osmetech Respiratory Pathogen Test Panel test has been adapted from QIAGEN’s QIAplex-based respiratory viral test for use on Osmetech’s eSensor XT-8 molecular diagnostics system, under the terms of an agreement signed in September 2008.